Shanghai RAAS(SZ:002252) Sou Hu Cai Jing·2025-08-13 13:47Group 1 - The core stock price of Shanghai Laishi (002252) closed at 6.94 yuan, with a slight increase of 0.14% and a turnover rate of 0.69% as of August 13, 2025 [1] - The company experienced a net outflow of main funds amounting to 36.62 million yuan, accounting for 11.54% of the total transaction amount, with significant outflows from large orders [1] - The latest financial report indicates that the total operating revenue for the first quarter of 2025 was 2.006 billion yuan, a year-on-year decrease of 2.45%, while the net profit attributable to shareholders was 566 million yuan, down 25.20% year-on-year [1] Group 2 - Shanghai Laishi Blood Products Co., Ltd. was established in 1988 and is primarily engaged in the pharmaceutical manufacturing industry, with a registered capital of approximately 663.80 million yuan [1] - The company has made investments in 25 enterprises and participated in 690 bidding projects, holding 40 trademark registrations and 38 patents, along with 362 administrative licenses [2]